Consolidated Statements of Redeemable Common Stock, Stock Options, Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Redeemable Common Stock	Notes Receivable for Redeemable Common Stock Issued	Redeemable stock options	Convertible Preferred Stock	Common Stock	Additional Paid-in Capital	Notes Receivable for Common Stock Issued	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Temporary Equity, Beginning Balance, Amount at Dec. 31, 2020		$ 80,780	$ 803	$ 53,085	$ 353,300
Temporary Equity, Beginning Balance, Shares at Dec. 31, 2020		3,813,450			14,376,272
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2020	$ (430,591)								$ (3)	$ (430,588)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2020						1
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares		280,545				83,958
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	347	$ 6,922		(5,715)			$ 347
Stock-based compensation expense	7,575						7,575
Proceeds from notes receivable	136							$ 136
Exercise of preferred stock warrants, net of shares withheld for exercise price	(2,011)				$ 3,912		(2,011)
Exercise of preferred stock warrants, net of shares withheld for exercise price, Shares					100,261
Conversion of preferred stock to common stock upon initial public offering	357,202				$ (357,212)	$ 15	357,187
Conversion of preferred stock to common stock upon initial public offering, shares					(14,476,533)	14,951,254
Surrender of common stock in exchange for cancellation of note receivable, Shares						(11,011)
Surrender of common stock in exchange for cancellation of note receivable							(229)	229
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock	86,885	$ (87,702)	817			$ 4	87,698	(817)
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock, shares		(4,093,995)				4,093,995
Reclassification of redeemable common stock options to common stock options	47,370			$ (47,370)			47,370
Change in notes receivable for common stock issued	452		$ (14)					$ 452
Issuance of common stock in connection with initial public offering, net of issuance costs of $12.4 million	119,582					$ 8	119,574
Issuance of common stock in connection with initial public offering, net of issuance costs of $12.4 million, shares						8,248,549
Fair Value of unexercised warrants	(7)
Net income loss	(48,688)									(48,688)
Stockholders' Equity, Ending Balance, Amount at Dec. 31, 2021	$ 138,242					$ 27	617,511		(20)	(479,276)
Stockholders' Equity, Ending Balance, Shares at Dec. 31, 2021	27,366,746					27,366,746
Other comprehensive loss	$ (17)								(17)
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares						382,506
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount	841					$ 1	840
Shares redeemed for employee tax withholdings, Share						(49,456)
Shares redeemed for employee tax withholdings, Amount	(643)						(643)
Shares issued for the employee stock purchase plan, Share						92,718
Shares issued for the employee stock purchase plan, Amount	937						937
Issuance of common stock in at-the-market offerings, net of issuance costs, Share						$ 475,875
Issuance of common stock in at-the-market offerings, net of issuance costs, Amount	5,959						5,959
Stock-based compensation expense	$ 11,397						11,397
Conversion of preferred stock to common stock upon initial public offering, shares	4,093,995
Issuance of common stock in connection with initial public offering, net of issuance costs of $12.4 million, shares	475,875
Fair Value of unexercised warrants	$ (66)
Net income loss	(66,756)									(66,756)
Stockholders' Equity, Ending Balance, Amount at Dec. 31, 2022	$ 89,902					$ 28	$ 636,001		(95)	$ (546,032)
Stockholders' Equity, Ending Balance, Shares at Dec. 31, 2022	28,268,389					28,268,389
Other comprehensive loss	$ (75)								$ (75)